Structure of hepatitis C virus envelope glycoprotein E2 antigenic site 412 to 423 in complex with antibody AP33

Journal of Virology

Volumn 86, Issue 23, 2012, Pages 13085-13088

  Kong, Leopold ^a   Giang, Erick ^a   Nieusma, Travis ^a   Robbins, Justin B ^a   Deller, Marc C ^a,b   Stanfield, Robyn L ^a   Wilson, Ian A ^a,b   Law, Mansun ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b Joint Center for Structural Genomics   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BROADLY NEUTRALIZING ANTIBODY AP33; GLYCINE; GLYCOPROTEIN E2; LEUCINE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY AP33; NEUTRALIZING ANTIBODY; TRYPTOPHAN; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANTIBODY SPECIFICITY; ANTIGEN ANTIBODY COMPLEX; ARTICLE; BETA SHEET; CRYSTAL STRUCTURE; DNA HAIRPIN; HEPATITIS C VIRUS; HUMAN; HYDROGEN BOND; NONHUMAN; PRIORITY JOURNAL; PROTEIN DNA INTERACTION; PROTEIN STRUCTURE; VIRUS ENTRY; VIRUS ENVELOPE; VIRUS NEUTRALIZATION;

ANTIBODIES, NEUTRALIZING; EPITOPES; HEPACIVIRUS; MODELS, MOLECULAR; PROTEIN CONFORMATION; VIRAL ENVELOPE PROTEINS;

HEPATITIS C VIRUS;

EID: 84869229723     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01939-12     Document Type: Article

References (12)

1. Broering TJ, et al. 2009. Identification and characterization of broadly neutralizing human monoclonal antibodies directed against the E2 envelope glycoprotein of hepatitis C virus. J. Virol. 83:12473-12482.
2. Burton DR. 2002. Antibodies, viruses and vaccines. Nat. Rev. Immunol. 2:706-713.
3. Dhillon S, et al. 2010. Mutations within a conserved region of the hepatitis C virus E2 glycoprotein that influence virus-receptor interactions and sensitivity to neutralizing antibodies. J. Virol. 84:5494-5507.
4. Dormitzer PR, Ulmer JB, Rappuoli R. 2008. Structure-based antigen design: a strategy for next generation vaccines. Trends Biotechnol. 26: 659-667.
5. Gal-Tanamy M, et al. 2008. In vitro selection of a neutralization-resistant hepatitis C virus escape mutant. Proc. Natl. Acad. Sci. U. S. A. 105:19450-19455.
6. Kong L, et al. 2012. Structural basis of hepatitis C virus neutralization by broadly neutralizing antibody HCV1. Proc. Natl. Acad. Sci. U. S. A. 109: 9499-9504.
7. Kwong PD, Wilson IA. 2009. HIV-1 and influenza antibodies: seeing antigens in new ways. Nat. Immunol. 10:573-578.
8. Owsianka A, Clayton RF, Loomis-Price LD, McKeating JA, Patel AH. 2001. Functional analysis of hepatitis C virus E2 glycoproteins and viruslike particles reveals structural dissimilarities between different forms of E2. J. Gen. Virol. 82:1877-1883.
9. Owsianka A, et al. 2005. Monoclonal antibody AP33 defines a broadly neutralizing epitope on the hepatitis C virus E2 envelope glycoprotein. J. Virol. 79:11095-11104.
10. Stanfield RL, Wilson IA. 1993. X-ray crystallographic studies of antibody-peptide complexes. Immunomethods 3:211-221.
11. Tarr AW, et al. 2006. Characterization of the hepatitis C virus E2 epitope defined by the broadly neutralizing monoclonal antibody AP33. Hepatology 43:592-601.
12. Wilson IA, Stanfield RL. 1993. Antibody-antigen interactions. Curr. Opin. Struct. Biol. 3:113-118.